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Abstract  
Oxidative stress is an important mechanism of chemical toxicity, contributing to developmental 
toxicity and teratogenesis as well as to cardiovascular and neurodegenerative diseases and 
diabetic embryopathy. Developing animals are especially sensitive to effects of chemicals that 
disrupt the balance of processes generating reactive species and oxidative stress, and those 
anti-oxidant defenses that protect against oxidative stress. The expression and inducibility of 
anti-oxidant defenses through activation of NFE2-related factor 2 (Nrf2) and related proteins is 
an essential process affecting the susceptibility to oxidants, but the complex interactions of Nrf2 
in determining embryonic response to oxidants and oxidative stress are only beginning to be 
understood. The zebrafish (Danio rerio) is an established model in developmental biology and 
now also in developmental toxicology and redox signaling.  Here we review the regulation of 
genes involved in protection against oxidative stress in developing vertebrates, with a focus on 
Nrf2 and related cap’n’collar (CNC)-basic-leucine zipper (bZIP) transcription factors. Vertebrate 
animals including zebrafish share Nfe2, Nrf1, Nrf2, and Nrf3 as well as a core set of genes that 
respond to oxidative stress, contributing to the value of zebrafish as a model system with which 
to investigate the mechanisms involved in regulation of redox signaling and the response to 
oxidative stress during embryolarval development. Moreover, studies in zebrafish have revealed 
nrf and keap1 gene duplications that provide an opportunity to dissect multiple functions of 
vertebrate NRF genes, including multiple sensing mechanisms involved in chemical-specific 
effects. 
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Introduction1 
Oxidative stress occurs when the cellular redox balance is altered, disrupting redox signaling 
and regulation [1-3]. It can occur through the generation and action of reactive species such as 
superoxide anion, hydrogen peroxide, peroxynitrite, and other reactive products that can alter 
thiol redox circuits [4-6]. Oxidative stress is increasingly recognized as a significant mechanism 
of chemical toxicity and as a contributing factor in a wide range of pathological conditions and 
diseases in adults, and in developing animals. The roles of reactive species and redox status in 
normal physiology, and the mechanisms underlying adverse effects of oxidative stress, have 
been studied extensively in adult animals and cells. However, less is known about the role of 
these processes in developmental disorders and chemical toxicity during embryonic and fetal 
development.   
Developing animals are uniquely sensitive to oxidative stress because of the rapid changes in 
cell proliferation and differentiation that occur at this time, and because enzymatic systems that 
protect against or repair toxic damage may not be fully mature early in development. The 
expression and inducibility of anti-oxidant defenses are critical factors affecting susceptibility to 
oxidative stress, but the ontogenic development of antioxidant defenses and their regulation in 
at early life stages are only beginning to be understood. The zebrafish (Danio rerio), an 
established model in developmental biology, has emerged recently as a valuable system for 
studying the expression and regulation of antioxidant defenses during development, and in 
particular the role of Nfe2-related transcription factors. Here we provide a review of the 
development and regulation of genes involved in protection against oxidative stress, with a 
focus on insights obtained from studies in zebrafish early life stages (embryos and larvae).  For 
an additional perspective on the use of zebrafish as a model to study oxidative mechanisms, 
please see a recent review [7]. 
 
Oxidant signaling and oxidative stress in development and developmental toxicology 
Importance of redox status and oxidant signaling during development 
Embryonic development involves precisely orchestrated processes--including proliferation, 
differentiation, apoptosis, establishment of left-right asymmetry, gene expression, and 
epigenetic modifications--that increasingly are found to depend on redox signaling and 
intracellular redox potentials (Eh) [8-16]. Because endogenous oxidants and cellular redox 
potential play such important and fundamental roles in normal embryonic development, tight 
regulation of redox balance is critical.  Toxicant exposures or other environmental stressors that 
increase oxidant levels or disrupt redox balance can fundamentally alter cell fate decisions. This 
can result in functional or structural changes, some of which could have long-term 
consequences that may only become apparent with subsequent stress or age [17, 18].  
 
Role of oxidative stress in developmental toxicity 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Abbreviations used:  ARE: anti-oxidant response element; CNC-bZIP: cap’n’collar basic-leucine zipper; 
CRISPR: clustered regularly interspaced short palindromic repeats; DEM: diethylmaleate; DQ: diquat; 
GFP: green fluorescent protein; GSH: glutathione; MO: morpholino oligonucleotide; NRF:  NFE2-related 
factor; RT-PCR: reverse transcription-polymerase chain reaction; SFN: sulforaphane; tBHQ: tert-
butylhydroquinone; tBOOH: tert-butylhydroperoxide; TILLING: Targeting Induced Local Lesions IN 
Genomes 	  
	   5	  
Oxidative stress contributes to a variety of human diseases [19-23] and has been implicated in 
the mechanism of action of human teratogens including valproic acid, phenytoin, ethanol, and 
thalidomide [16, 24-29], as well as in congenital malformations associated with PAH exposure 
[30, 31] and diabetic embryopathy [27, 32]. A variety of chemicals can generate reactive species 
or disrupt redox balance in other ways, through redox cycling, following biotransformation to 
reactive intermediates, or through induction or uncoupling of enzymes that can generate 
oxidants [33-36]. 
Studies of oxidative stress in adult organisms and cultured cells dominate the literature.  
However, developing animals (vertebrates including mammals and fish) are often more 
sensitive than young adults to chemical toxicity [37-40] and embryos appear to be especially 
sensitive to oxidative damage [24-27, 40, 41].  The risk of embryotoxicity and teratogenicity 
following exposure to pro-oxidant chemicals depends on the balance between reactions 
generating oxidative stress and reactions that are protective or repair the damage [24, 25, 41-
45].  Consistent with this, supplementation with small molecular anti-oxidants or stimulation of 
anti-oxidant enzymes protects embryos against the developmental toxicity of a variety of 
chemicals [46-55] and embryos with reduced antioxidant capacity are at increased risk for 
developmental toxicity and teratogenicity [24, 30, 44, 56-58]. 
 
Constitutive and inducible antioxidant defenses in embryos 
Anti-oxidant defenses can be constitutive, protecting against and balancing redox potential 
under normal physiological conditions, and inducible defenses, which protect against toxicant-
stimulated levels of oxidants or redox imbalance.  Embryos express relatively low basal 
(constitutive) levels of most anti-oxidants and anti-oxidant enzymes [59-67], which can put them 
at increased risk for oxidative toxicity [24, 25, 27]. Less is known about the inducible component 
of the anti-oxidant defense in embryos.  A number of studies have examined inducible anti-
oxidant defenses and the oxidative stress response in mammalian development [16, 17, 65, 68-
70]. These studies have demonstrated the capacity of vertebrate embryos to respond to 
oxidative stress with increased expression of anti-oxidant genes, and in some cases have 
demonstrated a role for NFE2-related factor 2 (Nrf2)2 [70, 71]. Several groups including ours 
have begun to examine the oxidative stress response in zebrafish embryos (see below).  These 
reports suggest that the responsiveness of embryos to oxidative stress can vary dramatically 
with developmental stage, and that this involves Nrf proteins. However, there is much yet to 
learn concerning the oxidative stress response in embryos and how it is regulated. Before 
discussing what has been learned from studies in zebrafish embryos, we briefly review what is 
known about the oxidative stress response and its regulation by NRF proteins in mammals. 
Additional details can be found in other reviews in this volume. 
 
The oxidative stress response – regulation by Nfe2-related factors 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  Nomenclature: NRF is a commonly used notation for NFE2-Related Factor genes, which are officially 
designated as NFE2L (NFE2-Like). For example, NRF2 is officially designated as NFE2L2, and NRF1 as 
NFE2L1. Throughout the paper, we use the more common NRF designation.  Otherwise, we utilize the 
approved format for designating genes and proteins 
(https://wiki.zfin.org/display/general/ZFIN+Zebrafish+Nomenclature+Guidelines). In particular, human 
genes and proteins are designated using all capitals (NRF2 and NRF2, respectively), whereas zebrafish 
genes are designated nrf2 and Nrf2 for genes and proteins, respectively. When not referring to a specific 
species, we have used the human notation as a default format. 	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Vertebrate animals possess an inducible enzymatic defense system that acts to detoxify 
reactive species and replenish the supply of small molecule anti-oxidants.  Oxidants, 
electrophiles, and some so-called anti-oxidant chemicals activate an oxidative stress response 
via a family of related, cap’n’collar (CNC)-basic-leucine zipper (bZIP) transcription factors that 
interact with an anti-oxidant response element (ARE; a.k.a. electrophile response element or 
EpRE: 5’-TGACnnnGC-3’) in the promoters of target genes [72-76]. Known target genes in 
mammals include GSTA1, GSTP, NQO1, GCL, SOD, heme oxygenase (HO-1), and others. 
The best-characterized oxidative stress response mechanism is that involving NRF2. NRF2 is 
normally found in the cytosol as an inactive complex with Kelch-like-ECH-associated protein 
(Keap1, also called iNRF2). Keap1 both retains NRF2 in the cytoplasm and enhances its 
proteasomal degradation [77-80]. Oxidative stress disrupts the interaction between NRF2 and 
Keap1 through a mechanism that may involve phosphorylation and/or disruption of sulfhydryl 
interactions [72, 81-87] affecting the nucleocytoplasmic shuttling of NRF2 [88, 89].  Once free of 
the repressor Keap1, NRF2 protein accumulates in the cell, enters the nucleus and forms a 
heterodimer with one of several small Maf proteins (MafF, MafG, MafK), which also contain 
bZIP motifs [90-92].  The NRF2-Maf dimer binds to AREs and activates transcription. A few 
studies suggest that Nrf2 may not dissociate from Keap1, but that the disruption of ubiquitination 
maintains Keap1 in a Nrf2-saturated state, permitting newly synthesized Nrf2 to travel 
unimpeded to the nucleus (e.g. reviewed in [93]). However, this remains controversial and has 
not yet been examined in zebrafish. Irrespective of whether Nrf2 dissociates from Keap1, or 
whether the de novo/Keap1 saturation model proves correct, accumulation of Nrf2 in the 
nucleus results in ARE-mediated gene regulation.  An additional layer of regulation is provided 
by the related proteins BACH1 (BTB and CNC homology 1) and BACH2, which can also act as 
repressors of NRF2 [94, 95].  
An oxidative stress response involving CNC proteins appears to be evolutionarily conserved in 
animals, with NRF homologs in Drosophila melanogaster [96, 97] and C. elegans [98, 99]. 
However, most of our current understanding of the oxidative stress response has been obtained 
from studies of the four mammalian CNC-bZIP proteins. 
Nuclear factor erythroid-2 (NFE2). NFE2 (also called p45) is a hematopoietic cell-specific 
transcription factor controlling globin gene expression as a complex with one of several small 
Maf proteins (p18) [100, 101].  NFE2 null mice are deficient in platelets and exhibit 
hemorrhaging and high mortality [102].  
NFE2-related factor-1 (NRF1; also called NFE2L1, TCF11 and LCR-F1). NRF1 is expressed in 
a variety of tissues [103] and as multiple isoforms [104].  Mice in which the Nrf1 gene has been 
disrupted die in utero either by day 7.5 or day 17.5 and exhibit a defect in definitive 
erythropoiesis [105, 106].  Studies in Nrf1-/-/Nrf1+/+ chimeric mice show that NRF1 is required for 
the development of the liver but not other tissues, that the effect is specific to hepatocytes, and 
that Nrf1-/- hepatocytes exhibit increased oxidative stress and undergo apoptosis late in pre-
natal development [107].  NRF1 interacts with the ARE and regulates the basal expression and 
inducibility of GCL [108] and NQO1 [109, 110]; it is also important for glutathione homeostasis 
[111]. NRF1 can also act as a repressor of gene expression [104, 112]. Unlike NRF2 (below), 
NRF1 is localized to the endoplasmic reticulum and may play a role in the response to ER 
stress [113]. NRF1 is involved in regulating lipid metabolism [112, 114] and the expression of 
proteasome subunits in response to oxidant-damaged proteins [115, 116]. 
NRF2 (NFE2L2)  NRF2 was initially cloned from humans [117] and chickens [118] (called ECH).  
NRF2 binds to ARE sequences in vitro [119] and experiments in NRF2-deficient mice show that 
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it regulates the basal and inducible expression of genes in the oxidative stress response, 
including NQO1, GSTP, GSTA, GSTM, GCL, ferritin, HO-1 [120-123] and other genes [124, 
125]. Unlike targeted disruption of NRF1, which is embryo-lethal, NRF2 knock-out mice develop 
and reproduce normally [126]. Interestingly, constitutive activation of NRF2 in Keap1-deficient 
mice leads to postnatal lethality [127]. Moreover, disruption of both NRF2 and NRF1 results in 
pronounced oxidative stress, apoptosis, and embryolethality at an earlier stage than seen in the 
Nrf1-/- mice, demonstrating that NRF1 and NRF2 both have developmentally important, partially 
overlapping roles [128]. In addition, although the Nrf2-/- single knock-out mice are viable, as 
adults they are much more sensitive to chemicals that cause oxidative stress [129-132], 
including benzo[a]pyrene (BaP) [133, 134].  Thus, NRF2 has a key role in mediating the 
oxidative stress response in adult animals. 
NRF3 (NFE2L3).  NRF3 is expressed in several tissues, most notably in the placenta and in B-
cell lineages [135, 136], and like NRF1 exists as several isoforms and is localized to the 
endoplasmic reticulum [137, 138]. NRF3-null mice develop normally and compound 
NRF3/NRF2 and NRF3/NF-E2 mutants exhibit no additional phenotypes [139]. However, NRF3-
null mice have increased susceptibility to benzo[a]pyrene-induced T-cell lymphoblastic 
lymphoma [140]. NRF3 can activate or repress gene expression and may act as a negative 
regulator of NRF2 [138, 141]. The role of NRF3 in protection against oxidative stress is currently 
unclear. 
Most information about the regulation of the oxidative stress response by NRF proteins has 
been obtained in adult mammals and mammalian cells.  What is the role of NRF-related 
transcription factors in regulating the response to oxidative stress in developing animals? 
 
Zebrafish as a model for studying development roles of Nrf2 and related proteins 
The zebrafish has emerged as a powerful system in which to examine mechanisms involved in 
the regulation of the oxidative stress response by Nrf2 and related proteins in developing 
animals. The zebrafish embryo is an important vertebrate model (or “tool” [142]) in embryology 
and developmental biology [143-153]. Because zebrafish are vertebrates, results obtained in 
this system have more direct relevance for humans as compared to studies in invertebrates. 
The fundamental features of developmental signaling pathways are conserved between fish and 
mammals, facilitating extrapolation of results from zebrafish to humans [151, 154-156].  
A key technical advantage of zebrafish is the external development of nearly transparent 
embryos, facilitating direct observation of all stages of embryonic development, something not 
possible in mammals. The small size, rapid development (~48-72 hr from fertilization to hatch), 
and short generation time (2-3 mo) of zebrafish allow for large numbers of animals to be 
produced and housed [157]. Transgenic technologies are well developed in zebrafish [158]; 
transient and stable (germline) expression of transgenes can be used to visualize cell lineages 
[159], test promoter function [160, 161], and map regulatory elements [162-164], all in vivo.  
Heterologous promoters and proteins have been shown to function faithfully in zebrafish, 
recapitulating native expression patterns [162] or rescuing mutant phenotypes [165]. The 
coupling of green fluorescent protein (GFP)-based reporters [166-168] and transparent 
zebrafish embryos provides a powerful system for visualizing in vivo gene expression.  
Saturation mutagenesis screens have been performed using chemical or insertional 
mutagenesis [169-172] and many of the mutants reproduce human genetic diseases [173, 174].  
Powerful loss-of-function approaches contribute to the utility of zebrafish in studying gene 
function. An anti-sense approach using morpholino-modified oligonucleotides (MOs) has been 
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widely used to produce targeted gene “knock-downs” in developing zebrafish [175-177].  This 
approach has been useful for identifying gene function during development [175, 178-183] and 
to understand the role of specific genes in mechanisms of toxicity [184-191]. More recently, a 
trio of gene targeting methods have been developed and applied to zebrafish, making it possible 
to generate null alleles and homozygous null mutants at any locus. These methods include 
DNA-based targeted endonuclease approaches involving zinc-finger nucleases (ZFN) and 
transcription activator-like effector nuclease (TALENS) [192-195], as well as the RNA-guided 
clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 approach [196, 197].  
Recent results comparing mutant and morphant phenotypes have highlighted the strengths and 
limitations of each approach [198-200]. 
A whole genome sequence supports a variety of genomic tools for studies in zebrafish [201, 
202], and affords explicit comparisons with other species.  Thus, zebrafish chromosomes exhibit 
large regions of conserved synteny with human chromosomes, facilitating studies of genome 
evolution and the identification of orthologous genes [203, 204].  An important advantage of 
zebrafish as a model is the existence of multiple copies of some human genes.  
In general, zebrafish share with humans most features of key biochemical pathways (including 
signaling pathways).  However, because of genome duplication in the teleost fish lineage shortly 
after its divergence from the tetrapod lineage [205-208], teleost fish have retained extra copies 
(paralogs) of some transcription factors, not found in humans. The existence of paralogs in fish 
provides an opportunity for new mechanistic insights, because duplicated fish genes might be 
exploited to obtain new information about the function of their single human counterpart [205-
207, 209, 210].  This might apply especially to human genes with multiple functions or 
expression domains. The duplication, degeneration, complementation model of gene evolution 
[209, 210] predicts that the multiple functions or complex expression patterns of such a gene in 
humans may be partitioned between its fish “co-orthologs,” so that each of the duplicates retains 
a subset of the original functions. By studying each paralog individually (e.g. by loss-of-function 
approaches), their distinct roles (subsets of the original roles or expression patterns) can be 
examined in isolation and thereby elucidated. This approach may be especially informative in 
studying pleiotropic transcription factors such as Nrf2, because it can help to reveal some of the 
subtle functions of the mammalian homolog.  
Because of these advantages, zebrafish were prominent among a group of alternative models 
recommended by the National Research Council for research in developmental toxicology [20]. 
More recently, the zebrafish model has been adopted and embraced by regulatory agencies 
and scientists in the U.S. and Europe [211-216] and by the pharmaceutical industry [217-224]. 
The number of studies in which this model system has been used to investigate mechanisms 
underlying the oxidative stress response was initially small [225-229], but has been rapidly 
growing.  The emerging picture is that the fundamental features of the oxidative stress response 
are conserved in vertebrates, and thus that zebrafish is a powerful model with which to 
investigate oxidative phenomena during development. 
Although there are many strengths of zebrafish as a model in which to study developmental 
processes, it is important to keep in mind that early in development (prior to the onset of 
circulation at ~26 hpf [230]), zebrafish embryos may experience a somewhat different oxygen 
environment than that experienced by mammalian embryos. Zebrafish embryos are typically 
cultured and develop at ambient [O2] [231, 232], whereas at early stages mammalian embryos 
experience lower oxygen tension, and higher concentrations can be toxic [233]. After the onset 
of circulation, however, zebrafish embryos are likely to experience oxygen environments similar 
to those of mammalian embryos. Thus, while the zebrafish embryo may be a valuable system 
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for investigating fundamental mechanisms underlying the developmental roles of Nrf2 and 
related proteins, as with any model there may also be unique features that must be considered 
in interpreting the results.  
 
Diversity of CNC-bZip transcription factors and related genes in zebrafish 
Studies over the past 15 years have begun to establish the molecular mechanisms underlying 
the regulation of the oxidative stress response in fish and their similarity to those in mammals. 
Early studies [225, 226] demonstrated that reporter gene constructs containing a luciferase 
gene under control of mammalian ARE sequences, when transfected into fish cells, could be 
induced by exposure to tert-butylhydroquinone (tBHQ), suggesting that fish oxidant-responsive 
transcription factors are able to recognize mammalian ARE sequences.  Subsequently, it was 
shown that exposure of zebrafish embryos or larvae to tBHQ or tert-butylhydroperoxide 
(tBOOH) induces an oxidative stress response [227, 234-237]. The first direct evidence for an 
oxidative stress response in fish and its mechanistic similarity to that in mammals was from 
Kobayashi et al. [227, 229], who cloned the cDNAs for zebrafish Nrf2 and Keap1 and showed 
that these proteins mediated the induction of gstp1, nqo1, and gclc by tBHQ in zebrafish 
embryos. Zebrafish also possess small Maf proteins (including a novel form, MafT) that form 
heterodimers with Nrf2 [238]. An evolutionarily conserved ARE 50-bp upstream of the gstp1 
transcriptional start site was shown to interact with Nrf2 to regulate gstp1 expression [228]. 
Since the initial studies in zebrafish cells and embryos, the number and identity of Nrf genes 
and their partners has become clear, revealing in some cases enhanced diversity in zebrafish 
as compared to humans.  As noted above, four CNC-bZIP family members exist in humans and 
other mammals: NFE2, NRF1 (NFE2L1), NRF2 (NFE2L2), and NRF3 (NFE2L3). Zebrafish have 
a single nfe2 gene that is expressed in erythroid cells and in the developing ear [239]. The 
function of zebrafish nfe2 is not well understood, but loss-of-function studies involving 
knockdown of Nfe2 by morpholino oligonucleotides suggested that nfe2 may be required for 
proper cellular organization in the pneumatic duct and subsequent swim bladder function, as 
well as for proper formation of the otic vesicles [240].  In contrast to the single NRF1 gene in 
humans, zebrafish have two nrf1 paralogs (nrf1a, nrf1b)3 [234, 241], whose functions are not yet 
known. In addition to the original nrf2 gene [227] (now known as nrf2a), a second nrf2 gene 
(nrf2b [234]) has been identified. Overall, Timme-Laragy et al. [234] found that zebrafish (Danio 
rerio) possess six nrf genes, including nfe2, nrf3, and duplicated nrf1 and nrf2 genes. 
Comparative genomic analysis demonstrated extensive conserved synteny involving human 
and zebrafish nrf2 and hox genes (Fig. 1), indicating that nrf2a and nrf2b are co-orthologs of 
human NRF2, and nrf1a and nrf1b are co-orthologs of NRF1. The conserved synteny suggests 
that the nrf1 and nrf2 duplicates—like the hox clusters to which they are linked—arose as part of 
the fish-specific whole-genome duplication that occurred after divergence of fish and 
mammalian lineages [207, 242]. In general, the comparative genomic analyses demonstrated 
strong support for the hypothesis that the zebrafish nrf genes are orthologs (nfe2; nrf3) or co-
orthologs (nrf1a and nrf1b; nrf2a and nrf2b) of the corresponding human NRF genes.   Zebrafish 
nrf genes are summarized in Table 1. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  The designation of duplicated genes (and their encoded proteins) as “a” (as in nrf1a) or “b” (nrf1b) is 
according to the approved zebrafish nomenclature for duplicates resulting from the fish-specific whole-
genome duplication (https://wiki.zfin.org/display/general/ZFIN+Zebrafish+Nomenclature+Guidelines).  	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The HOX genes have important and well-established roles in embryonic development [245]. 
The conservation of the syntenic relationship between the HOX clusters and all of the NFE2-
related genes suggest that there has been strong selective pressure to preserve this 
arrangement over 500 million years of evolution. This has been seen also for other HOX-
associated genes and in comparisons of human and pufferfish (Takifugu rubripes) genomes 
[246, 247].  An intriguing possibility is that there may be coordinated regulation of these genes 
during development—a possible example of “genomic regulatory blocks”—large regions of 
conserved synteny and conserved gene order with overlapping regulatory features that resist 
recombination [248, 249].  Notably, all six of the NFE2-related genes are expressed in embryos 
[234, 240] (see below), supporting a plausible regulatory association with the HOX 
developmental patterning genes. 
Similar to the findings with nrf1 and nrf2, zebrafish also possess duplicated keap1 genes 
(keap1a and keap1b [227, 229]) and duplicated bach1 genes (bach1a, bach1b [250, 251]). 
Together, these results demonstrate that duplicated zebrafish genes are common in the Nrf 
pathways, as they are in some other pathways involved in regulation of response to 
environmental stressors [252, 253].  
 
Ontogeny of glutathione redox dynamics and constitutive antioxidant defenses in 
developing embryos 
In addition to the oxidative stress response and developmental events regulated by the Nrf- 
family of transcription factors, other endogenous antioxidant defenses play important roles in 
embryonic development. Glutathione (GSH) is the most abundant cellular antioxidant, present in 
mM concentrations, and is required for successful embryonic development [254, 255]. 
Importantly, numerous studies have demonstrated a strong relationship between concentrations 
and nuclear localization of GSH and cell cycle progression [256-259]. Cell fate decisions have 
also been shown to be closely related to GSH Eh, with more oxidized Eh associated with 
differentiation, and more reduced Eh with proliferation [260-262].  
Timme-Laragy et al. [263] assessed GSH homeostasis during embryonic development by 
measuring GSH redox dynamics over 0-120 hours of zebrafish development. They used high-
performance liquid chromatography (HPLC) to measure reduced and oxidized glutathione 
(GSH, GSSG) and calculated the whole embryo total glutathione (GSHT) concentrations and 
redox potentials (Eh) at each of twelve stages. The results (Fig. 2) revealed distinct windows of 
GSH concentration and redox status that correspond to major developmental events. Initially (at 
fertilization and shortly after), embryos have relatively low concentrations of GSHT and reducing 
conditions. Subsequently (3-24 hpf) concentrations of GSHT remain low (2-3 mM) but the redox 
potential becomes more oxidized. From 30-48 hpf, concentrations of GSHT increase while the 
redox potential remains oxidized. This is a period of cellular differentiation, which would be 
promoted at a cellular level by an oxidized redox status [260-262]. After hatching, GSH 
concentrations remain high and the redox potential becomes more reduced, conditions that 
promote cellular proliferation [261]. These results suggest that embryonic development involves 
a highly regulated trajectory of glutathione status involving changes in both the amount and 
oxidation state of this important regulator of cellular redox status. Studies in other fish 
demonstrate similar cycles of GSH regulation during development [264, 265].   
Timme-Laragy et al. [263] also identified the set of zebrafish orthologs of mammalian genes 
involved in glutathione synthesis, recycling, and utilization and measured their expression 
during development. They identified in the zebrafish genome extensive duplication of genes 
encoding proteins involved in GSH synthesis and recycling, and these genes exhibited complex 
patterns of gene expression in developing embryos. A number of the genes involved in GSH 
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synthesis were maternally loaded and/or expressed highly in early embryos. Overall, ontogenic 
changes in the expression of GSH-related genes supported the hypothesis that GSH redox 
status is tightly regulated during development. However, the role of Nrf proteins and other 
transcription factors in regulating the constitutive expression of these genes in embryos is not 
yet well understood. 
 
Developmental expression of Nfe2-related genes and inducible antioxidant defenses 
The constitutive expression of genes involved in antioxidant defense may help to ensure that 
redox conditions are appropriate for normal embryonic development, and may provide some 
immediate protection against challenges posed by exposure to chemicals or other stressors.  In 
addition, embryos possess the ability to up-regulate antioxidant defenses in response to 
challenges, but how these inducible responses vary by cell type and developmental stage and 
how they are regulated during development are poorly known.    
Kobayashi et al. [227] found that exposure of zebrafish larvae to tBHQ (30 µM) for 6 hr at 4- or 
7-days post fertilization (dpf) caused the induction of gstp1, nqo1, and gclc. However, exposure 
of 24-hpf embryos to tBHQ for 6 hours did not induce gstp1, suggesting that 24-hr old zebrafish 
embryos are less capable of mounting an oxidative stress response. Timme-Laragy et al. [235] 
found induction of gstp1, gpx1, and gclc in zebrafish embryos exposed to tBOOH or ß-
naphthoflavone for 24 hr beginning at 24-hpf, suggesting that at some point during the 24-48-
hpf period the embryos are capable of responding to these chemicals. A recent study [237] 
showed that tBHQ exposure for 6 hr caused strong induction of gstp1 in 1- and 2-dpf embryos. 
tBHQ also induced gclc (1-, 2-, and 4-dpf), but not sod1 or nqo1. Together, these reports 
suggest that there are stage- or chemical-specific differences in responsiveness to oxidative 
stress during development.  
 
Gene expression profiles  
A few studies have gene expression profiles in embryos exposed to oxidant chemicals.  In a 
comparison of responses of zebrafish larvae to eleven different chemicals using microarrays, 
Yang et al. [236] found that tBHQ at 5-dpf produced a distinct profile that included a number of 
genes known from studies in mammals to be involved in the oxidative stress response. 
Nakajima et al. [266] reported that exposure of 4-dpf larvae to the sulfhydryl-reactive chemical 
diethylmaleate (DEM) induced 42 genes by more than 2-fold, including gclc, txnrd1 (thioredoxin 
reductase 1), peroxiredoxin 1, and several gst genes.  In another study [237], microarray 
analysis of gene expression in 4-dpf larvae acutely exposed to tBHQ showed a robust 
response, with both up-regulated genes (220 genes induced by more than 2-fold) and down-
regulated genes (109 genes). The induced genes included several involved in the synthesis and 
utilization of GSH and other sulfhydryl-reactive anti-oxidants (thioredoxin) and their regulation, 
including gclc, gclm, glutathione synthase (gss), GSH reductase (gr1), gamma-glutamyl 
transferase (ggt1a), and cystathionine beta-synthase (cbsb). There was substantial overlap 
(10/15) between genes induced in these larvae and a set of marker genes induced by oxidative 
stress in mammals (Table 2), demonstrating the evolutionary conservation in the oxidative 
stress response. 
 
Developmental expression of nrf genes   
How the expression of nrf genes and Nrf proteins varies during development is not fully 
understood, but current data suggest that there are substantial differences in developmental 
patterns (ontogeny), levels, and localization. Expression of nrf2a mRNA as assessed by RT-
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PCR is low in early embryos (≤24 hpf), but increases substantially from 2- to 7-dpf [268]. A 
similar pattern was seen using quantitative RT-PCR [234] and microarray [240]. Interestingly, 
microarray data suggest that nrf3 mRNA is maternally loaded and that levels of nrf3 expression 
through the first two days of embryonic development are much greater (by several orders of 
magnitude) than those of any other nrf gene [240].  
Localization of nrf gene expression also varies by gene and developmental stage.  As noted 
earlier, zebrafish nfe2 is expressed in erythroid cells and in the developing ear [239]. The 
expression of nrf2a mRNA at 24 hpf is restricted to the olfactory system, but by 5-dpf this gene 
is more widely expressed, appearing also in gill, liver, and intestine [266]. Expression of nrf2a 
mRNA is also seen in the exocrine pancreas at 84 hpf [250]. The expression of nrf3 mRNA is 
localized to fore, mid- and hindbrain and pectoral fin buds between 24- and 36-hpf [240].  The 
localization of nrf1 paralogs and nrf2b is not known. These patterns of tissue-, cell- and 
developmental stage-specific expression suggest that there are specific and varying needs for 
regulating redox status, and also that there are target cells, tissues, or stages that may be more 
susceptible to non-physiological oxidant challenge; neither of these is well understood.   
 
Functional assessment of Nfe2-related genes in development and developmental toxicity 
Loss-of-function approaches to define the roles of Nrf proteins 
Measurements of gene expression—whether of nrf genes themselves or their putative target 
genes—provide intriguing associations but do not reveal regulatory relationships or 
mechanisms.   In contrast, loss-of-function experiments in which the expression or function of a 
protein is reduced or eliminated can provide valuable mechanistic information about the role of 
that protein. The primary approach used so far to elucidate the functional roles of Nrf proteins in 
zebrafish embryos has been knock-down of protein expression using morpholino-modified anti-
sense oligonucleotides (MOs) [175]. Although questions have arisen recently about the use of 
the MO approach to identify functions of novel genes [198-200], MO-based knock-down remains 
a valuable method for testing specific hypotheses about the role of transcription factors in 
regulating putative target genes.   
Several groups have used MO-mediated knock down of Nrf2a to assess the role of this protein 
in the regulation of gene expression in zebrafish embryos in response to oxidant exposure.  
Some of these results are summarized in Table 3.  These studies show that a number of 
oxidant-inducible genes (and at least one repressed gene) are under control of Nrf2a; the genes 
include some well-known Nrf2 targets such as gstp1, gclc, hmox1, and prdx1.  However, other 
oxidant-inducible genes do not appear to be regulated via Nrf2a (Table 3), suggesting that other 
transcription factors may be involved in controlling their induction.   
A recent study [244] compared the tBHQ-induced gene expression profiles in 2-dpf zebrafish 
embryos in which either Nrf2a or Nrf2b had been knocked down.  Knockdown of Nrf2a or Nrf2b 
blocked some but not all of the tBHQ-induced changes in gene expression and the effects of 
Nrf2a-MO and Nrf2b-MO were distinct. The results indicated that Nrf2 paralogs regulate distinct 
gene sets, with some overlapping targets, in response to oxidative stress in embryos. This study 
also highlighted the importance of gene down-regulation as a component of the oxidative stress 
response during embryonic development. 
Much less is known about the role of other Nrf proteins, including the Nrf1 paralogs and Nrf3, in 
regulating specific genes in response to oxidative stress. Studies in mammals (e.g. [269, 270]) 
suggest that much will be learned by defining the sets of genes regulated by each Nrf protein in 
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embryos.  In addition, other redox-sensitive transcription factors may be involved in regulating 
the response to oxidant exposure (see below). 
 
 
 
In addition to regulating the induction (or repression) of oxidant-responsive genes, Nrf proteins 
are likely to be involved in the regulation of constitutive (basal) expression of some genes. For 
example, Timme-Laragy et al. [234] performed gene expression profiling of Nrf2a-MO-injected 
embryos and Nrf2b-MO-injected embryos and found that Nrf2a and Nrf2b regulate distinct but 
partially overlapping gene sets even in the absence of chemical exposure. In Nrf2a-morphants, 
198 probes were up-regulated, whereas 310 were down-regulated as compared with embryos 
injected with the control-MO. In contrast, Nrf2b-morphants had more up-regulated probes (280) 
than down-regulated probes (254), suggesting that Nrf2b can act as a repressor of constitutive 
gene transcription during development. 
The loss-of-function caused by MO-based knock-down is partial and temporary. Thus, while MO 
experiments can help to identify functions during early development, they may miss functions 
occurring later or that can proceed in the presence of reduced Nrf protein expression.  A more 
powerful approach to defining gene function is to generate null mutants in which the expression 
of a gene or function of its encoded protein is completely eliminated.  While such an approach is 
common in mice and has been applied extensively to understand the role of murine Nrf proteins 
(see above), application of this approach to understand Nrf function in zebrafish is in its infancy.  
Two point mutants of zebrafish nrf2a have been generated using the approach known as 
TILLING (Targeting Induced Local Lesions in Genomes [274, 275]). Each of these mutants 
(nfe2l2fh318 (R485L) and nfe2l2fh319 (N494I)) possesses a single amino acid change in a 
conserved residue in the basic region near the C-terminal end of the Nrf2 protein [243].  
Kobayashi and colleagues [243] found that the protein encoded by the nfe2l2fh319 mutant 
retained activity, but that the transcriptional activity of the protein encoded by the nfe2l2fh318 
allele was greatly reduced. Homozygous nfe2l2fh318 mutant fish were viable and fertile, similar to 
what is seen in Nrf2-knock-out mice [126]. However, mutant fish were more sensitive to the 
toxicity of H2O2 and other peroxides and certain electrophilic compounds, but not to some other 
oxidants [243]. The mechanism responsible for this increased sensitivity may involve a 
reduction in the ability to mount an oxidative stress response.  Consistent with this, the induction 
of gstp1, prdx1, txn1, and gclc by H2O2 was greatly reduced in homozygous mutant larvae as 
compared to wild-type larvae [243].  
The nfe2l2fh318 fish are also being used by other groups [273, 276, 277] to explore the role of 
nrf2a in protection against chemicals that cause oxidative stress. 
 
Chemical specificity: patterns and mechanisms 
A variety of chemicals can disrupt redox balance by generating oxidants or reacting with 
sulfhydryl groups, and thereby activate an oxidative stress response.  There are questions 
about the mechanisms by which these chemicals activate this response in embryos. For 
example, do they act through Nrf2 or other Nrf proteins? Do chemicals that act by different 
mechanisms produce the same gene expression response?   
A number of genes that are induced by oxidant exposure are shared in zebrafish and humans, 
and in a given species exposed to different oxidants [236, 237, 266, 267]. A recent study [278] 
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examined the set of oxidant responsive genes that is induced by structurally distinct activators 
of the oxidative stress response in developing zebrafish. Zebrafish larvae (4 dpf) were exposed 
to tBHQ, tBOOH, diquat (DQ), or sulforaphane (SFN)) and gene expression was measured 6 hr 
later by microarray and Q-RT-PCR. The compounds caused overlapping but distinct patterns of 
altered gene expression. A core set of genes responded to all oxidants. However, other genes 
exhibited oxidant-specific changes in expression. Principal components analysis revealed that 
the changes in gene expression caused by SFN, a sulfhydryl-reactive agent, were distinct from 
those produced by the other oxidants. The results demonstrate that the oxidative stress 
response in developing animals is dependent upon the nature of the oxidative stress.   
Kobayashi and colleagues [268, 279, 280] have begun to elucidate some of the mechanisms by 
which distinct responses might be produced for different chemicals.  Their studies of this 
“multiple sensing mechanism” have identified six classes of inducers based in part upon which 
cysteines in Keap1 are targeted for oxidation.  Additional mechanisms may involve activation of 
different Nrf paralogs.  For example, MO knockdown studies in zebrafish embryos have shown 
that Nrf2a and Nrf2b regulate distinct gene sets, with only a small number of overlapping target 
genes [244].  The roles of other Nrf proteins—including Nrf1a, Nrf1b, and Nrf3—in regulating the 
response of developing animals to oxidative stress are completely unknown.  Beyond the Nrf 
gene family, there are other redox-sensitive transcription factors such as AP-1, NFκB, p53, and 
HIF [281, 282] that may be involved in generating chemical-specific effects.    
 
Conclusions and Future Directions 
Regulation of constitutive and inducible defenses against oxidative stress by Nfe2-related 
factors is an evolutionarily conserved feature of animals. Conservation is especially evident 
among vertebrate animals, which share Nfe2, Nrf1, Nrf2, and Nrf3, as well as a core set of 
genes that respond to oxidative stress [227, 234, 237]. This conservation contributes to the 
value of zebrafish as a model system with which to investigate the mechanisms involved in 
regulation of redox signaling and the response to oxidative stress during embryo-larval 
development. Studies in zebrafish have revealed nrf and keap1 gene duplications that provide 
an opportunity to dissect multiple functions of vertebrate NRF genes, including multiple sensing 
mechanisms involved in chemical-specific effects.  
Important questions about the regulation of the oxidative stress response in developing animals 
remain to be answered. We highlight three areas where substantial progress can be expected.  
One concerns the role of different Nrf homologs and paralogs in such regulation, and how it may 
vary by cell type and stage of development. Understanding the roles of Nrf proteins will be 
facilitated by gene-targeting and genome-editing approaches such as CRISPR-Cas9 [196, 197]. 
This method, first used for gene inactivation in 2013, has now exploded and is being used for a 
variety of applications, including single-nucleotide genome editing [283, 284].  This is a 
transformative technology that is dramatically enhancing our ability to manipulate systems to 
better understand gene function. It is possible, for example, to introduce known human 
polymorphisms into zebrafish nrf or keap1 genes to better understand how they affect Nrf 
protein function during development.  
Another important goal is to understand the localized generation of oxidants and oxidative 
stress and the consequent responses. Use of transgenic technologies [158, 285] will facilitate 
new insight into the cell and tissue specificity of the oxidative stress response in embryos.  Initial 
studies have begun to address such questions, using molecular probes to localize oxidative 
stress [7] and transient [228, 286] and germ-line transgenics [279, 287] to measure the 
response.  
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A third topic of great interest and where progress should be substantial in the near future is 
cross-talk between Nrf signaling pathways and other stress-response and developmental 
signaling pathways.  One example is the aryl hydrocarbon receptor (AHR) signaling pathway, 
involved in both developmental processes and the response to endogenous and exogenous 
chemicals. Interactions between AHR and NRF signaling occur in mammals [288-291] and 
recent studies suggest that such interactions also occur in zebrafish embryos [234, 277, 292]. In 
addition to the AHR pathway, there are several other signaling pathways that engage in cross-
talk with Nrf signaling in mammalian systems.  Some of these pathways include those involving 
Hsf1, Notch, NFκB, PPARγ/RXR, and the unfolded protein response [93, 293-298].  Whether 
any of these interact with Nrf signaling during development remains to be determined. 
Although substantial progress has been made in using the zebrafish embryo system to 
understand the role of Nrf proteins in regulating the oxidative stress response in developing 
animals, much remains to be done. The next few years will be an exciting time as new 
approaches are applied in novel ways to address longstanding questions about Nrf function 
during development. 
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Figure captions 
 
Fig. 1.  Comparative genomics of NFE2-related genes in zebrafish. Location and shared 
synteny involving NFE2-related genes and HOX genes in the human genome (top) and 
zebrafish genome (bottom). This research was originally published in The Journal of 
Biological Chemistry. Timme-Laragy et al., Nrf2b, Novel Zebrafish Paralog of Oxidant-
responsive Transcription Factor NF-E2-related Factor 2 (NRF2). The Journal of Biological 
Chemistry. 2012; Vol. 287: 4609-4627. [234] © the American Society for Biochemistry and 
Molecular Biology. 
 
Fig. 2.  Concentrations of GSHT and Eh during the first 120 hours of zebrafish 
development.  
Four “windows” of dynamic glutathione conditions during embryonic development are 
observed. A) reduced Eh and low GSHT , observed in mature oocytes; B) oxidized Eh and 
low GSHT, observed in embryos from the mid-blastula transition through somitogenesis (3-
24 hpf); C) oxidized Eh and high GSHT , observed in embryos undergoing organ 
differentiation (30-48 hpf), and D) reduced Eh and high GSHT, observed in post-hatch 
eleutheroembryos.  Reproduced, with permission, from Timme-Laragy et al. [263]. 
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TABLES 
 
 
 
Table 1.  nfe2-related genes in zebrafish   
 
genea protein Expression 
during 
development 
Morphant 
phenotype 
Mutants 
available 
References 
nfe2 Nfe2 yes; localized swim bladder, 
otic vesicles 
no [234, 239, 240] 
nrf1a (nfe2l1a) Nrf1a yes noneb no [234, 240] 
nrf1b (nfe2l1b) Nrf1b yes none no [234, 240] 
nrf2a (nfe2l2a) Nrf2a yes, localized; 
increasing 0-5 dpf 
gene 
expression 
nfe2l2fh318 
(R479L)  
[227, 234, 240, 
243, 244] 
nrf2b (nfe2l2b) Nrf2b yes gene 
expression 
no [234, 240, 244] 
nrf3 (nfe2l3) Nrf3 high none no [234, 240] 
 
Notes: 
a Commonly used gene name is given.  When different from the common name, the official gene name is 
provided in parentheses. 
b None = no phenotype detected so far, but phenotypes may be revealed upon further analysis. 
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Table 2.  Genes induced by exposure to tBHQ: Comparison of mammals and zebrafish. 
 	  
Marker gene in mammals 
Zebrafish  
tBHQ / DMSO 
(co)-orthologs 
      
HSP70 1A, 1B, 6 
hsp70 (Chr.3) 52.3 
hsp70l (Chr.8) 15.5 
HSP70 9B hspa9 (Chr.14) 1.2 
HSP90 1 alpha 
hsp90a (Chr.20) 1.2 
hsp90a2 (Chr.20) 10.4 
DnaJ (Hsp40) B1 
dnajb1a (Chr.3) 1.4 
dnajb1b (Chr.1) 10.5 
NAD(P)H quinone 
oxidoreductase-1 (NQO1) nqo1 0.7 
Glutamate-cysteine ligase, 
modifier subunit gclm 4.1 
Thioredoxin (TXN) 
txn1 (Chr.7) 5.5 
txn2 (Chr.1) 0.8 
Thioredoxin reductase-1 txnrd1 1.6 
Glutathione reductase glutathione reductase 1 3.8 
Ferritin, heavy polypeptide-1 
fth1 (Chr.7) 1.0 
ferritin-like (Chr.3) 6.8 
ferritin-like (Chr.25) 0.7 
Ferritin light polypeptide ferritin L 0.9 
Carbonyl reductase-1 cbr1 1.1 
Phosphogluconate 
dehydrogenase pgd 2.5 
Sequestosome-1 sqstm1 7.6 
Ubiquitin thioesterase usp4 1.0 
 
 
A set of 20 candidate genes, based on the multiple data sets of genes responding to oxidative 
stress in mammalian cells, was compiled by Johnson and colleagues, as listed in Table 2 of Li 
et al. [267]. Here, the 20 mammalian candidate genes have been collapsed into 15 sets based 
on orthologous or co-orthologous relationships with zebrafish genes and including only those 
genes with orthologs represented on the Agilent zebrafish microarray. Of these 15 genes, 10 
have at least one co-ortholog induced by tBHQ in 4-dpf zebrafish (indicated in bold type and 
green shading), whereas 5 are not induced under these conditions.  This table is modified from 
Table 1 of Hahn et al. [237]; use is permitted by the Creative Commons Attribution license.  
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Table 3.  Use of MO-mediated knock-down to determine Nrf-dependencea of altered gene 
expression in oxidant-exposed zebrafish embryos.   
 
Gene Inducer Age Nrf2a-
dependence? 
Reference 
bcat1 DEM 4 dpf Yes [266] 
ferric-chelate 
reductase 1 
DEM 4 dpf Yes [266] 
ferritin heavy chain DEM 4 dpf Yes [266] 
gclc tBOOH, ANF + BNF 2 dpf Yes [235] 
gclc CdCl2 4 dpf Yes [271] 
gpx1 tBOOH, ANF + BNF 2 dpf Yes [235] 
gsta1 DEM 4 dpf Yes [266] 
gstp tBHQ 4 dpf Yes [227] 
gstp1/gstp2 tBOOH, ANF + BNF 2 dpf Yes [235] 
gstp CdCl2 4 dpf Yes [271] 
gstp1 DEM 4 dpf Yes [266] 
gstp1 tBHQ 2 dpf Yes [234] 
hmox1 CdCl2 4 dpf Yes [271] 
hmox1 PFOS 4 dpf Yes [272] 
mitfa tBHQ 2 dpf Yesb [234] 
peroxiredoxin 1 DEM 4 dpf Yes [266] 
prdx1 CdCl2 4 dpf Yes [271] 
prdx1 GSNORi 54 hpf Yes [273] 
sepw2b DEM 4 dpf Yes [266] 
sod1 ANF + BNF 2 dpf Yes [235] 
sod2 ANF + BNF 2 dpf Yes [235] 
abcc2 DEM 4 dpf No [266] 
atf3 tBHQ 2 dpf No [234] 
bc2 DEM 4 dpf No [266] 
cx32.3 DEM 4 dpf No [266] 
hsp70 tBHQ 2 dpf No [234] 
txnrd1 DEM 4 dpf No [266] 
ugdh DEM 4 dpf No [266] 
a Nrf2a-dependence is defined as genes showing a reduction of induction (or repression) by chemical 
in embryos injected with Nrf2a-MO as compared to a control MO. 
b Gene is repressed, rather than induced, by chemical treatment. 
Abbreviations used:  ANF: alpha-naphthoflavone; BNF: beta-naphthoflavone; DEM:  diethylmaleate; 
GSNORi: S-nitrosoglutathione reductase (GSNOR) inhibitor N6547; PFOS:  perfluorooctane sulfonate; 
tBHQ:  tert-butylhydroquinone; tBOOH: tert-butylhydroperoxide. 
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